DaVita Inc. (DVA) Earnings Call Transcripts
DaVita Inc.'s Latest Earnings Call - Q3 FY2026
In the third quarter of 2026, DaVita Inc. reported adjusted operating income of $561 million and adjusted earnings per share of $3.82, reflecting solid operational performance amid ongoing investments in technology and clinical innovations. Management raised guidance for Integrated Kidney Care (IKC) adjusted operating income to at least $65 million, an increase of $25 million over prior expectations, while narrowing full-year guidance for adjusted operating income to a range of $2.175 billion to $2.25 billion and adjusted earnings per share to $14.30 to $15.20. The company is poised for future growth driven by its new expanded HD dialyzer rollout and ongoing improvements in patient care metrics, although rising technology costs remain a concern.
Reported metrics
| Metric | Value |
|---|---|
| Adjusted Operating Income | $561 million |
| Adjusted Earnings Per Share | $3.82 |
| Full Year Adjusted Operating Income Guidance | $2.175 billion to $2.25 billion (inline) |
| IKC Adjusted Operating Income | $65 million (beat) |
| Free Cash Flow | $276 million |
Guidance from management
Management narrowed full-year guidance for adjusted operating income to $2.175 billion to $2.25 billion and for adjusted earnings per share to $14.30 to $15.20, reflecting increased IKC performance offset by higher U.S. dialysis costs.
What management said
Sure, I'll take that one, A.J., this is Javier. We agree with you. Our confidence and our capabilities in both the clinical and actuarial areas have now reached a point where we want to pursue more business. As we've stressed, what you want is healthy contracts, and you want your physician partners to be heavily involved. Our model of care is now scalable, and you need integrative tech, which we now have. We've got a...
Thank you. I hope you can hear how excited we are in our voices, along with our physicians, our patients, and our caregivers; this ranks among the most excitement I've ever witnessed in the community. The brief response to your questions is that it's too early to say. This takes time, as the mortality studies show, and it takes time before any effect appears on the inflammatory side. When it comes to patients changin...
What analysts pressed on
Analysts expressed concerns regarding the impact of rising technology costs and the potential headwinds from the expiration of enhanced premium tax credits affecting patient volumes. There were also inquiries about the sustainability of treatment growth rates given recent mistreatment upticks.
Main topics on the call
- Integrated Kidney Care Performance — DaVita's Integrated Kidney Care business is outperforming expectations, with management stating, "We now expect IKC to deliver at least $65 million of adjusted operating income in 2026, an increase of at least $25 millio...
- Technology Investments Impact — Management highlighted that investments in technology have exceeded forecasts, stating, "Our IT investments in U.S. dialysis is higher than we forecasted heading into the year," which has negatively impacted financial pe...
- Expanded HD Dialyzer Rollout — The rollout of the expanded HD dialyzer is set to begin next week, with management noting, "We will begin our national rollout next week and expect a swift network-wide transition." This innovation is expected to enhance...
- Mortality Improvement Metrics — DaVita reported a 10% improvement in achieving optimal fluid removal and a nearly 5-pound reduction in average patient weight, which management attributed to enhanced clinical protocols, stating, "These advancements are ...
Read the full DaVita Inc. transcript (Q3 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About DaVita Inc.
DaVita Inc. (DVA) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on New York Stock Exchange and is based in US. EarningsCalls.dev maintains a full-text archive of its earnings call transcripts — 28 calls on record spanning February 10, 2020 to October 29, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics. The latest calls are free to read; the full history is available through our REST API.
Earnings Call History
EarningsCalls.dev has 28 DaVita Inc. earnings call transcripts on record, spanning February 10, 2020 to October 29, 2026. Based on this history, DaVita Inc. reports quarterly. The most recent call on file is dated October 29, 2026. The full list is below — each row opens the transcript.
- Ticker
- DVA
- Exchange
- New York Stock Exchange
- Country
- US
- Sector
- Health Care
- Calls on record
- 28
- First call
- February 10, 2020
- Most recent
- October 29, 2026
- Reporting cadence
- quarterly